<prompt> Ipilimumab is aAnti CD30 Monoclonal AntibodyPDL1 receptor inhibitorCTLA4 inhibitorPTPN22 inhibitor  <response>: Ipilimumab and Tremelimumab are CTLA4 inhibitors used in BRAF -ve malignant melanoma. 